Target
CREBBP
4 abstracts
Abstract
Genomic profiling in a subgroup analysis of patients (pts) with diffuse large B-cell lymphoma (DLBCL) and extranodal (EN) sites of involvement in the phase 3 Pola-R-CHP versus R-CHOP (POLARIX) study.Org: Centre Henri-Becquerel and University of Rouen, University Hospital Münster, M.D. Anderson Cancer Center, Charles University General Hospital, University of Montpellier,
Abstract
Integrative genomic analysis examines molecular and clinical disparities between bladder urothelial carcinoma and upper tract urothelial carcinoma.Org: Konyang University Hospital,
Abstract
Genomic determinants of outcome in acute lymphoblastic leukemia: A Children’s Oncology Group study.Org: St. Jude Children’s Research Hospital, Memphis, TN, The Hospital for Sick Children, Toronto, ON, Canada, Perlmutter Cancer Center and NYU Langone, New York, NY, Children's Hospital of Alabama, Birmingham, AL, Children's Hospital Colorado, Aurora, CO,
Abstract
Predictive value of co-existing genetic alterations and tumor mutation burden for patients with completely resected non-small cell lung cancer harboring EGFR mutation: Biomarker analysis of phase III IMPACT study.Org: Kanagawa Cardiovascular and Respiratory Center, National Cancer Center Hospital East, Kashiwa, Japan, Kindai University Faculty of Medicine, Osaka-Sayama, Japan, Department of Data Sciences, Internal Medicine III, Wakayama Medical University,